Search research articles
Contact Us
Filters
Showing results (151-160 of 238) with videos related to
Page
of 24
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
October 13, 2006
Effect of enzyme replacement therapy with imiglucerase on BMD in type 1 Gaucher disease
Richard J Wenstrup, Katherine A Kacena, Paige Kaplan, et al.
Blood Cells, Molecules & Diseases
|
November 15, 2016
Reported outcomes of 453 pregnancies in patients with Gaucher disease: An analysis from the Gaucher outcome survey
Heather Lau, Nadia Belmatoug, Patrick Deegan, et al.
American Journal of Hematology
|
February 18, 2026
Excess Risk of Monoclonal Gammopathy in Patients With Gaucher Disease
Majdolen Istaiti, Katie Thoren, Dickran Kazandjian, et al.
Orphanet Journal of Rare Diseases
|
January 29, 2025
Evaluation of Lyso-Gb1 as a biomarker for Gaucher disease treatment outcomes using data from the Gaucher Outcome Survey
Ari Zimran, Shoshana Revel-Vilk, Tama Dinur, et al.
Molecular Genetics and Metabolism
|
April 9, 2011
A safety trial of high dose glyceryl triacetate for Canavan disease
Reeval Segel, Yair Anikster, Shoshana Zevin, et al.
American Journal of Hematology
|
February 24, 2018
Glucosylsphingosine is a reliable response biomarker in Gaucher disease
David Arkadir, Tama Dinur, Shoshana Revel-Vilk, et al.
Systematic Reviews
|
April 22, 2017
Plasma chitotriosidase activity versus CCL18 level for assessing type I Gaucher disease severity: protocol for a systematic review with meta-analysis of individual participant data
Tatiana Raskovalova, Patrick B Deegan, Ruby Yang, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
April 6, 2007
Monitoring of Gaucher patients with a novel chitotriosidase assay
Aricha Schoonhoven, Bernard Rudensky, Debbie Elstein, et al.
Molecular Genetics and Metabolism
|
September 12, 2016
Home infusion of intravenous velaglucerase alfa: Experience from pooled clinical studies in 104 patients with type 1 Gaucher disease
Deborah Elstein, T Andrew Burrow, Joel Charrow, et al.
Blood
|
March 20, 2010
Phase 1/2 and extension study of velaglucerase alfa replacement therapy in adults with type 1 Gaucher disease: 48-month experience
Ari Zimran, Gheona Altarescu, Mici Philips, et al.
Page
of 24
Search research articles
Search
Showing results (151-160 of 238) with videos related to
Sort By:
Page
of 24
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
October 13, 2006
Effect of enzyme replacement therapy with imiglucerase on BMD in type 1 Gaucher disease
Richard J Wenstrup, Katherine A Kacena, Paige Kaplan, et al.
Blood Cells, Molecules & Diseases
|
November 15, 2016
Reported outcomes of 453 pregnancies in patients with Gaucher disease: An analysis from the Gaucher outcome survey
Heather Lau, Nadia Belmatoug, Patrick Deegan, et al.
American Journal of Hematology
|
February 18, 2026
Excess Risk of Monoclonal Gammopathy in Patients With Gaucher Disease
Majdolen Istaiti, Katie Thoren, Dickran Kazandjian, et al.
Orphanet Journal of Rare Diseases
|
January 29, 2025
Evaluation of Lyso-Gb1 as a biomarker for Gaucher disease treatment outcomes using data from the Gaucher Outcome Survey
Ari Zimran, Shoshana Revel-Vilk, Tama Dinur, et al.
Molecular Genetics and Metabolism
|
April 9, 2011
A safety trial of high dose glyceryl triacetate for Canavan disease
Reeval Segel, Yair Anikster, Shoshana Zevin, et al.
American Journal of Hematology
|
February 24, 2018
Glucosylsphingosine is a reliable response biomarker in Gaucher disease
David Arkadir, Tama Dinur, Shoshana Revel-Vilk, et al.
Systematic Reviews
|
April 22, 2017
Plasma chitotriosidase activity versus CCL18 level for assessing type I Gaucher disease severity: protocol for a systematic review with meta-analysis of individual participant data
Tatiana Raskovalova, Patrick B Deegan, Ruby Yang, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
April 6, 2007
Monitoring of Gaucher patients with a novel chitotriosidase assay
Aricha Schoonhoven, Bernard Rudensky, Debbie Elstein, et al.
Molecular Genetics and Metabolism
|
September 12, 2016
Home infusion of intravenous velaglucerase alfa: Experience from pooled clinical studies in 104 patients with type 1 Gaucher disease
Deborah Elstein, T Andrew Burrow, Joel Charrow, et al.
Blood
|
March 20, 2010
Phase 1/2 and extension study of velaglucerase alfa replacement therapy in adults with type 1 Gaucher disease: 48-month experience
Ari Zimran, Gheona Altarescu, Mici Philips, et al.
Page
of 24